LSB
Price
$2.72
Change
+$0.37 (+15.74%)
Updated
Jan 17 closing price
Capitalization
51.96M
STTK
Price
$1.11
Change
+$0.02 (+1.83%)
Updated
Jan 17 closing price
Capitalization
52.99M
59 days until earnings call
Ad is loading...

LSB vs STTK

Header iconLSB vs STTK Comparison
Open Charts LSB vs STTKBanner chart's image
LakeShore Biopharma
Price$2.72
Change+$0.37 (+15.74%)
Volume$13.25K
Capitalization51.96M
Shattuck Labs
Price$1.11
Change+$0.02 (+1.83%)
Volume$117.31K
Capitalization52.99M
LSB vs STTK Comparison Chart
Loading...
LSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LSB vs. STTK commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSB is a Hold and STTK is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (LSB: $2.72 vs. STTK: $1.11)
Brand notoriety: LSB and STTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LSB: 59% vs. STTK: 45%
Market capitalization -- LSB: $51.96M vs. STTK: $52.99M
LSB [@Biotechnology] is valued at $51.96M. STTK’s [@Biotechnology] market capitalization is $52.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LSB’s FA Score shows that 1 FA rating(s) are green whileSTTK’s FA Score has 1 green FA rating(s).

  • LSB’s FA Score: 1 green, 4 red.
  • STTK’s FA Score: 1 green, 4 red.
According to our system of comparison, both LSB and STTK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LSB’s TA Score shows that 3 TA indicator(s) are bullish while STTK’s TA Score has 3 bullish TA indicator(s).

  • LSB’s TA Score: 3 bullish, 6 bearish.
  • STTK’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, STTK is a better buy in the short-term than LSB.

Price Growth

LSB (@Biotechnology) experienced а -11.59% price change this week, while STTK (@Biotechnology) price change was -6.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

STTK is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STTK($53M) and LSB($52M) have the same market capitalization . STTK YTD gains are higher at: -8.264 vs. LSB (-21.301). STTK has higher annual earnings (EBITDA): -76.01M vs. LSB (-220.1M). STTK has more cash in the bank: 90.1M vs. LSB (49.5M). STTK has less debt than LSB: STTK (3.62M) vs LSB (369M). LSB has higher revenues than STTK: LSB (672M) vs STTK (6.44M).
LSBSTTKLSB / STTK
Capitalization52M53M98%
EBITDA-220.1M-76.01M290%
Gain YTD-21.301-8.264258%
P/E RatioN/AN/A-
Revenue672M6.44M10,443%
Total Cash49.5M90.1M55%
Total Debt369M3.62M10,207%
TECHNICAL ANALYSIS
Technical Analysis
LSBSTTK
RSI
ODDS (%)
Bearish Trend 11 days ago
40%
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
34%
Bearish Trend 11 days ago
82%
Momentum
ODDS (%)
Bearish Trend 11 days ago
47%
Bullish Trend 11 days ago
82%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
66%
Bullish Trend 11 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
44%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
74%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
Bearish Trend about 1 month ago
90%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
41%
Bearish Trend 11 days ago
88%
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
LSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REYN27.090.25
+0.93%
Reynolds Consumer Products
LMAT99.060.83
+0.84%
LeMaitre Vascular
CTAS198.310.26
+0.13%
Cintas Corp
SGU11.74N/A
N/A
Star Group LP
PRE5.66-0.27
-4.63%
Prenetics Global Limited

LSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, LSB has been loosely correlated with STTK. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LSB jumps, then STTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSB
1D Price
Change %
LSB100%
+16.12%
STTK - LSB
38%
Loosely correlated
+1.83%
BCTX - LSB
30%
Poorly correlated
-1.82%
GNFT - LSB
23%
Poorly correlated
+0.73%
GLTO - LSB
23%
Poorly correlated
+10.78%
SKYE - LSB
21%
Poorly correlated
-1.48%
More